全文获取类型
收费全文 | 23331篇 |
免费 | 1597篇 |
国内免费 | 530篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 718篇 |
妇产科学 | 224篇 |
基础医学 | 3756篇 |
口腔科学 | 227篇 |
临床医学 | 1287篇 |
内科学 | 3457篇 |
皮肤病学 | 252篇 |
神经病学 | 463篇 |
特种医学 | 432篇 |
外国民族医学 | 1篇 |
外科学 | 1304篇 |
综合类 | 1920篇 |
现状与发展 | 3篇 |
一般理论 | 2篇 |
预防医学 | 7320篇 |
眼科学 | 94篇 |
药学 | 2319篇 |
5篇 | |
中国医学 | 280篇 |
肿瘤学 | 1300篇 |
出版年
2024年 | 34篇 |
2023年 | 678篇 |
2022年 | 1204篇 |
2021年 | 1176篇 |
2020年 | 974篇 |
2019年 | 931篇 |
2018年 | 939篇 |
2017年 | 845篇 |
2016年 | 844篇 |
2015年 | 972篇 |
2014年 | 1247篇 |
2013年 | 1692篇 |
2012年 | 1218篇 |
2011年 | 1446篇 |
2010年 | 1199篇 |
2009年 | 1208篇 |
2008年 | 832篇 |
2007年 | 1008篇 |
2006年 | 910篇 |
2005年 | 759篇 |
2004年 | 744篇 |
2003年 | 692篇 |
2002年 | 505篇 |
2001年 | 442篇 |
2000年 | 369篇 |
1999年 | 319篇 |
1998年 | 249篇 |
1997年 | 243篇 |
1996年 | 186篇 |
1995年 | 160篇 |
1994年 | 122篇 |
1993年 | 125篇 |
1992年 | 82篇 |
1991年 | 107篇 |
1990年 | 90篇 |
1989年 | 83篇 |
1988年 | 77篇 |
1987年 | 65篇 |
1986年 | 61篇 |
1985年 | 118篇 |
1984年 | 92篇 |
1983年 | 80篇 |
1982年 | 61篇 |
1981年 | 52篇 |
1980年 | 43篇 |
1979年 | 40篇 |
1978年 | 32篇 |
1977年 | 29篇 |
1976年 | 20篇 |
1975年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
D LILIC J E CALVERT A J CANT M ABINUN G P SPICKETT 《Clinical and experimental immunology》1996,105(2):213-219
Patients with chronic mucocutaneous candidiasis (CMC) succumb to persistent infections with the opportunistic yeast Candida. Impaired cell-mediated responses to Candida have been repeatedly reported while antibody responses were mostly found to be normal. The underlying defect remains poorly understood. It has recently been shown that CMC patients are also susceptible to infections with encapsulated bacteria, and may have associated IgG2 and IgG4 deficiency. Our previous studies demonstrated altered cytokine production in CMC patients. As cytokines can influence production and isotype of specific antibody, in 10 patients with CMC we measured the levels and isotype distributions of serum antibodies to Candida antigens (CAg), pneumococcal polysaccharide (PPS) and tetanus toxoid (TT) antigens. Peripheral blood lymphocytes were also stimulated in culture and the antibodies made in vitro were measured. Our data demonstrated that in vivo, CMC patients had very high levels of IgG and IgA CAg-specific antibodies. CAg-specific and PPS-specific IgG1 was markedly higher than in controls. Children but not adults with CMC had significantly lower levels of IgG2-specific antibody to CAg and PPS compared with age-matched controls. Patients had significantly higher levels of IgG3-specific antibody to all three antigens tested. These findings were in accordance with increased total IgG and IgG3 levels seen in CMC patients. In vitro, CMC patients, particularly children, did not respond as frequently to antigen stimulation as did their healthy controls. The level of specific antibody produced was also lower to all antigens tested, as was the amount of total immunoglobulins following antigenic and particularly mitogenic stimulation. Addition of interferon-alpha (IFN-α) or IFN-γ to cultures had variable, sometimes marked, effects. Our results demonstrate that CMC patients manifest subtle alterations in specific antibody responses to CAg, PPS and TT, which are most pronounced in children. This may relate to altered cytokine production also seen in these patients. 相似文献
122.
C. B. Laval A. L. S. S. de rade F. C. Pimenta J. G. de Andrade R. M. de Oliveira S. A. Silva E. C. de Lima J. L. Di Fabio S. T. Casagrande M. C. C. Brandileone 《Clinical microbiology and infection》2006,12(1):50-55
Nasopharyngeal carriage of Streptococcus pneumoniae is a key factor in the development of invasive disease and the spread of resistant strains within the community. A single nasopharyngeal swab was obtained from 648 unvaccinated children aged <5 years, either healthy or with acute respiratory tract infection or meningitis, during the winters of 2000 and 2001. The overall pneumococcal carriage rate was 35.8% (95% CI 32.1-39.6). The pneumococcal serotypes found most frequently in the nasopharynx were 14, 6B, 6A, 19F, 10A, 23F and 18C, which included five of the seven serotypes in the currently licensed seven-valent conjugate vaccine (PCV7); serotypes 4 and 9V were less common. Serotypes 1 and 5 were isolated rarely from the nasopharynx. A comparison of 222 nasopharyngeal isolates with 125 invasive isolates, matched for age and time to the carrier isolates, showed a similar prevalence of penicillin non-susceptible pneumococci (PNSp) (19.8% and 19.2%, respectively). PNSp serotypes were similar (6B, 14, 19F, 19 A, 23B and 23F) for carriage and invasive disease isolates. The coverage of PCV7 for carriage isolates (52.2%) and invasive isolates (62.4%) did not differ significantly (p 0.06); similarly, there was no significant difference in PCV7 coverage for carriage isolates (34.5%) and invasive isolates (28.2%) of PNSp. These data suggest that PCV7 has the potential to reduce pneumococcal carriage and the number of carriers of PNSp belonging to vaccine serotypes. 相似文献
123.
124.
目的 探讨表达中国株HIV 1gp12 0基因的核酸疫苗在小鼠体内的免疫反应。方法 将表达HIV 1gp12 0的核酸疫苗质粒pVAXP经肌肉注射免疫Balb c小鼠 ,检测免疫小鼠脾CD4 +、CD8+T细胞亚群的数量 ,脾特异性CTL杀伤活性和血清抗体滴度。结果 重组质粒pVAXP免疫组小鼠脾CD4 +、CD8+T细胞亚群的数值均比对照组高 (P <0 .0 5 ) ;免疫组脾特异性CTL杀伤活性与对照组相比差异极显著 (P <0 .0 1) ;血清抗体滴度显著高于对照组 (P <0 .0 5 )。结论 表达HIV 1gp12 0基因的核酸疫苗质粒pVAXP能诱导小鼠产生特异性细胞和体液免疫。 相似文献
125.
Elevated interleukin-18 levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia 总被引:3,自引:0,他引:3
BACKGROUND: Interleukin (IL)-18 can induce Th2 cytokine production particularly in collaboration with IL-2. Accumulation of Th2 cells and increased levels of Th2 cytokines are found in bronchoalveolar lavage fluid (BALF) from patients with eosinophilic pneumonia (EP). To evaluate the role of IL-18 in the pathogenesis of EP, we measured the concentration of IL-2, IL-12, IL-18, and Th2 cytokines in BALF from patients with EP. METHODS: The concentrations of interferon (IFN)-gamma, IL-2, IL-5, IL-10, IL-12, IL-13, and IL-18 in BALF were measured in patients with idiopathic acute eosinophilic pneumonia (AEP), with idiopathic chronic eosinophilic pneumonia (CEP), with sarcoidosis and healthy volunteers (HV). RESULTS: The BALF concentrations of Th2 cytokines, IL-5, IL-10, and IL-13, were higher in patients with EP than in sarcoidosis and control. The IL-2 level in BALF was higher in EP than in sarcoidosis and control. The IL-18 and IL-12 (p40 + p70) levels were higher in patients with EP than sarcoidosis, while the level of IL-12 (p70) was below the detection limit in patients with EP. There was a significant correlation between IL-2 level and both IL-5 and IL-13 in BALF of patients with EP. CONCLUSIONS: Our findings suggest that IL-18 may contribute to Th2 cytokine-dominant responses in patients with EP in collaboration with IL-2. 相似文献
126.
127.
人白细胞介素13cDNA的克隆及序列测定 总被引:1,自引:0,他引:1
用反转录-多聚酶链反应(RT-PCR)技术从中国人外周血淋巴细胞中克隆了IL-13cDNA,序列测定表明克隆的IL-13cDNA含成熟的IL-13蛋白全部编码,且存在编码第98位Gln的密码子CAG,这为进一步表达IL-13并深入探究功能奠定了基础。 相似文献
128.
Matthias G. Pauthner Joseph P. Nkolola Colin Havenar-Daughton Ben Murrell Samantha M. Reiss Raiza Bastidas Jérémie Prévost Rebecca Nedellec Benjamin von Bredow Peter Abbink Christopher A. Cottrell Daniel W. Kulp Talar Tokatlian Bartek Nogal Matteo Bianchi Hui Li Jeong Hyun Lee Salvatore T. Butera Dennis R. Burton 《Immunity》2019,50(1):241-252.e6
129.
Nigel A. Cunliffe Bimal K. Das Madhumati Ramachandran Maharaj K. Bhan Roger I. Glass Jon R. Gentsch 《Virus genes》1997,15(1):39-44
We have sequenced the genes encoding the inner capsid protein VP6 and the nonstructural proteins NSP1 and NSP4 of the Indian
neonatal serotype P8[11]G9 human/bovine reassortant candidate vaccine rotavirus strain 116E. These three genes share a high
degree of sequence and deduced amino acid homology with human prototype strain Wa. Our results confirm and extend those of
previous RNA-RNA hybridization studies which suggested that these genes are of human origin, and will facilitate examination
of the host immune response to 116E induced by natural infection and vaccination.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
130.
R. Del Canho P. M. Grosheide M. Voogd W. M. Huisman R. A. Heijtink S. W. Schalm 《Journal of medical virology》1993,41(1):30-34
The immunogenicity of a full dose (20 μg) of recombinant DNA yeast-derived hepatitis B vaccine (Engerix-B) was assessed in healthy neonates in order to compare three candidate vaccination schemes. After randomization 162 newborns of hepatitis B surface antigen (HBsAg) negative mothers entered the study. Neonates received hepatitis B vaccine according to a fourdose vaccination scheme starting either at month 3 (scheme I: months 3,4,5, and 11) or at birth (scheme III: months 0,1,2, and 11). Another group of neonates received hepatitis B vaccine according to a three-dose scheme starting at birth (scheme II: months 0, 1, and 6). Serious adverse reactions were not observed; 2.5% of the vaccinated newborns suffered mild transient local symptoms. The vaccine was highly immunogenic irrespective of vaccination scheme; all infants developed anti-HBs levels ≥10 IU/L, 97% ≥100 IU/L. The immunogenicity of hepatitis B vaccine after primary and booster vaccinations, administered in the four-dose scheme started at birth, was significantly higher (P< 0.05) than in the three-dose scheme started at birth. Hepatitis B vaccination according to the four-dose scheme started at month 3 produced significantly higher (P < 0.05) antibody levels in comparison to the four-dose scheme started directly after birth. This study showed that a fourdose hepatitis B vaccination scheme starting at month 3 resulted in the highest antibody levels of the three schemes investigated and can be recommended for incorporation in the Expanded Programme on Immunization in The Netherlands. 相似文献